A multicenter, open-label, comparative trial of two daclizumab dosing strategies versus no antibody induction in simultaneous kidney-pancreas transplantation: 6-month interim analysis

Author: Stratta R.J.   Alloway R.R.   Hodge E.   Lo A.   Pancreas Investigators Vital Outcomes Trial PIVOT Study Group  

Publisher: Elsevier

ISSN: 0041-1345

Source: Transplantation Proceedings, Vol.34, Iss.5, 2002-08, pp. : 1903-1905

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content